ישראל - עברית - Ministry of Health

d.r.h.dental marketin - רופא - אביזרים , חומרים התקנים ונלווים המשמשים ברפואת שיניים

ישראל - עברית - Ministry of Health

vitamed pharmaceutical industries ltd - dipyrone - סירופ - dipyrone 1.25 g / 5 ml - pyrazolones - relief of moderate to severe pain as in headache, toothache, dysmenorrhea andfor high fever that does not respond to other measures.

ישראל - עברית - Ministry of Health

beit-erez havat milatin ltd - firocoxib - טבליות לעיסות - firocoxib 57 mg - for the relief of pain and inflammation associated with osteoarthritis in dogs. for the relief of post-operative pain and inflammation associated with soft-tissue surgery in dogs.for the relief of post-operative pain and inflammation associated with orthopaedic and dental surgery in dogs

ישראל - עברית - Ministry of Health

beit-erez havat milatin ltd - firocoxib - טבליות לעיסות - firocoxib 227 mg - for the relief of pain and inflammation associated with osteoarthritis in dogs.for the relief of post-operative pain and inflammation associated with soft-tissue surgery in dogs.for the relief of post-operative pain and inflammation associated with orthopaedic and dental surgery in dogs

ישראל - עברית - Ministry of Health

megapharm ltd - trospium chloride - טבליות מצופות - trospium chloride 20 mg - trospium - trospium - symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder (e.g. idiopathic or neurologic detrusor overactivity) .

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - benzoic acid as sodium; guaiacolsulfonate as potassium; oxomemazine - סירופ - oxomemazine 1.65 mg / 5 ml; benzoic acid as sodium 33.3 mg / 5 ml; guaiacolsulfonate as potassium 33.3 mg / 5 ml - oxomemazine - oxomemazine - antitussive expectorant.

ישראל - עברית - Ministry of Health

אלקליל בעמ - איפור

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - urofollitrophin highly purified (hpfsh) 75 iu/vial - powder for solution for injection - urofollitropin - anovulation (including polycystis ovarian disease (pcod) in women who have been unresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (evf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

ישראל - עברית - Ministry of Health

merck serono ltd - follitropin alfa - אבקה להכנת תמיסה לזריקה - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of sperma

ישראל - עברית - Ministry of Health

merck serono ltd - follitropin alfa - תמיסה להזרקה - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - gonal-f followed by chorionic gonadotrophin (hcg), is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf), gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermat